Extremely low excretion of daptomycin into breast milk of a nursing mother with methicillin-resistant Staphylococcus aureus pelvic inflammatory disease

scientific article published in March 2009

Extremely low excretion of daptomycin into breast milk of a nursing mother with methicillin-resistant Staphylococcus aureus pelvic inflammatory disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1592/PHCO.29.3.347
P698PubMed publication ID19249952

P2093author name stringMartha I Buitrago
Shellie Bertolami
Donald S North
Jason A Crompton
Richard A Nathan
P2860cites workInvasive methicillin-resistant Staphylococcus aureus infections in the United StatesQ29616087
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infectionsQ34330270
Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001.Q34471101
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureusQ34558111
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremiaQ34783668
Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjectsQ34882125
Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteersQ35091557
Drug excretion into breast milk--overviewQ35111467
Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogensQ35701450
Position of the American Dietetic Association: Promoting and supporting breastfeedingQ36121759
Antibiotic therapy for acute pelvic inflammatory disease: the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelinesQ36753465
Intrauterine devices - upper and lower genital tract infectionsQ36832774
Vaginal flora and pelvic inflammatory diseaseQ37890540
Adherence to oral therapies in pelvic inflammatory diseaseQ43730081
Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized TrialQ43996846
Breastfeeding and the Use of Human MilkQ54152651
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectStaphylococcus aureusQ188121
pelvic inflammatory diseasesQ558070
methicillin-resistant Staphylococcus aureusQ595158
P304page(s)347-351
P577publication date2009-03-01
P1433published inPharmacotherapyQ7180800
P1476titleExtremely low excretion of daptomycin into breast milk of a nursing mother with methicillin-resistant Staphylococcus aureus pelvic inflammatory disease
P478volume29

Reverse relations

cites work (P2860)
Q48240081Daptomycin excretion into human milk.
Q37583910Excretion of antimicrobials used to treat methicillin-resistant Staphylococcus aureus infections during lactation: safety in breastfeeding infants